SCHEMBL14975308

SCHEMBL14975308

CCCCCCCCCc1ccc2[nH]cc(CCN)c2c1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR1A P08908 12/20 1.00
HTR1D P28221 12/20 1.00
HTR1B P28222 11/20 1.00
HTR2A P28223 6/20 0.67
MAPT P10636 2/20 0.67
MAPK1 P28482 2/20 0.67
TDP1 Q9NUW8 2/20 0.67
CYP1A2 P05177 2/20 0.67
CYP3A4 P08684 2/20 0.67
CYP2D6 P10635 2/20 0.67
CYP2C9 P11712 2/20 0.67
KDM4E B2RXH2 1/20 0.67
TP53 P04637 1/20 0.67
CYP2C19 P33261 1/20 0.67
MEN1 O00255 1/20 0.65
KMT2A Q03164 1/20 0.65
NPSR1 Q6W5P4 1/20 0.65
TRPM8 Q7Z2W7 3/20 0.55
MPO P05164 1/20 0.55
HTR3E A5X5Y0 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8920992 0.99 HTR1A (0.97) HTR1AHTR1DHTR1BHTR2AMAPT
SCHEMBL1913860 0.88 HTR1A (0.81) HTR1AHTR1DHTR1BHTR2AMAPT
Pyrrole SCHEMBL28770264 0.88 HTR1A (0.85) HTR1AHTR1DHTR1BHTR2AMAPT
SCHEMBL4512060 0.84 HTR1A (1.00) HTR1AHTR1DHTR1BHTR2AMAPT
SCHEMBL29018529 0.84 HTR1A (0.78) HTR1AHTR1DHTR1BHTR2AMAPT
SCHEMBL5461625 0.83 HTR1A (0.71) HTR1AHTR1DHTR1BHTR2AMAPT
Hydrochloric Acid SCHEMBL7809324 0.82 HTR1A (0.97) HTR1AHTR1DHTR1BHTR2AMAPT
SCHEMBL12809571 0.82 HTR1A (0.70) HTR1AHTR1DHTR1BHTR2AMAPT
SCHEMBL8299143 0.81 HTR1A (0.77) HTR1AHTR1DHTR1BHTR2AMAPT
SCHEMBL10778563 0.81 HTR1A (0.74) HTR1AHTR1DHTR1BMPO

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150024008-A1 Methods and Compositions Involving Induced Senescent Cells for Cancer Treatment UNIV CHICAGO (US) 2015-01-22 US claimed
WO-2013078392-A1 METHODS AND COMPOSITIONS INVOLVING INDUCED SENESCENT CELLS FOR CANCER TREATMENT THE UNIVERSITY OF CHICAGO (US) 2013-05-30 WO claimed
US-20240255509-A1 COMPOSITIONS AND METHODS RELATED TO K180 DIMETHYLATED H1.0 PROTEIN AELAN CELL TECH INC (US) 2024-08-01 US disclosed
US-20230279147-A1 H1.0K180ME2 ANTIBODIES, METHODS OF MAKING AND USES THEREOF AELAN CELL TECH INC (US) 2023-09-07 US disclosed
US-11505621-B2 H1.0K180me2 antibodies, methods of making and uses thereof AELAN CELL TECHNOLOGIES, INC. (US) 2022-11-22 US disclosed
US-20200362056-A1 H1.0K180ME2 ANTIBODIES, METHODS OF MAKING AND USES THEREOF AELAN CELL TECHNOLOGIES, INC. (US) 2020-11-19 US disclosed
CN-111770761-A H1.0K180ME2 antibody, method for producing same, and use thereof 爱兰细胞技术公司 2020-10-13 CN disclosed
EP-3700569-A1 H1.0K180ME2 ANTIBODIES, METHODS OF MAKING AND USES THEREOF Aelan Cell Technologies, Inc. (US) 2020-09-02 EP disclosed
US-20190322729-A1 COMPOSITIONS AND METHODS RELATED TO K180 DIMETHYLATED H1.0 PROTEIN AELAN CELL TECHNOLOGIES, INC. 2019-10-24 US disclosed
CN-109415431-A COMPOSITIONS AND METHODS RELATED TO K180 DIMETHYLATED H1.0 PROTEIN 爱兰细胞技术公司 2019-03-01 CN disclosed
WO-2017184895-A2 COMPOSITIONS AND METHODS RELATED TO Κ180 DIMETHYLATED H1.0 PROTEIN AELAN CELL TECHNOLOGIES, INC. (US) 2017-10-26 WO disclosed
WO-2017002120-A1 SELECTIVE INHIBITORS OF SENESCENT CELLS AND USES THEREOF YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) 2017-01-05 WO disclosed
US-20150024008-A1 Methods and Compositions Involving Induced Senescent Cells for Cancer Treatment UNIV CHICAGO (US) 2015-01-22 US disclosed
WO-2013078477-A2 SOLUBILIZATION OF CURCUMINOID COMPOUNDS AND PRODUCTS THEREOF PAYNE ADAM J (US) 2013-05-30 WO disclosed
WO-2013078392-A1 METHODS AND COMPOSITIONS INVOLVING INDUCED SENESCENT CELLS FOR CANCER TREATMENT THE UNIVERSITY OF CHICAGO (US) 2013-05-30 WO disclosed